Puma Biotech (PBYI) Tops Q3 EPS by 113c

Puma Biotech (NASDAQ: PBYI) reported Q3 EPS of ($1.36), $1.13 better than the analyst estimate of ($2.49). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $3.74 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
• Ford (F) earnings top estimates in Q1 amid strength in Pro unit; stock up